KAS
WST icon

Kestra Advisory Services’s West Pharmaceutical WST Stock Holding History

Kestra Advisory Services’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,228
Closed -$613K – 4409
2025
Q4 		$613K Sell
2,228
-88
-4% -$24.1K ﹤0.01% 1992
2025
Q3 		$607K Sell
2,316
-396
-15% -$96.2K ﹤0.01% 1928
2025
Q2 		$593K Sell
2,712
-507
-16% -$108K ﹤0.01% 1847
2025
Q1 		$721K Buy
3,219
+740
+30% +$204K ﹤0.01% 1589
2024
Q4 		$812K Buy
2,479
+234
+10% +$73.6K ﹤0.01% 1533
2024
Q3 		$674K Buy
2,245
+80
+4% +$24.5K ﹤0.01% 1567
2024
Q2 		$713K Buy
2,165
+274
+14% +$96.8K ﹤0.01% 1532
2024
Q1 		$748K Sell
1,891
-175
-8% -$64.7K 0.01% 1418
2023
Q4 		$727K Buy
2,066
+95
+5% +$33.6K 0.01% 1289
2023
Q3 		$740K Sell
1,971
-158
-7% -$61.1K 0.01% 1155
2023
Q2 		$814K Sell
2,129
-103
-5% -$36.8K 0.01% 1076
2023
Q1 		$773K Sell
2,232
-3,054
-58% -$892K 0.01% 1062
2022
Q4 		$1.24M Sell
5,286
-81
-2% -$19.2K 0.01% 953
2022
Q3 		$1.32M Sell
5,367
-95
-2% -$28.9K 0.01% 837
2022
Q2 		$1.65M Buy
5,462
+2,338
+75% +$761K 0.02% 746
2022
Q1 		$1.28M Buy
3,124
+219
+8% +$85.7K 0.01% 850
2021
Q4 		$1.36M Buy
2,905
+244
+9% +$105K 0.01% 853
2021
Q3 		$1.13M Buy
2,661
+201
+8% +$84.7K 0.01% 954
2021
Q2 		$883K Sell
2,460
-13
-0.5% -$4.29K 0.01% 1004
2021
Q1 		$697K Buy
+2,473
New +$708K 0.01% 1028

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Kestra Advisory Services's WST Position: Q1 2026 in Review

Kestra Advisory Services sold out of West Pharmaceutical (WST) in Q1 2026, closing a stake of 2,228 shares — an estimated $613K sold.

Kestra Advisory Services first reported a position in WST in Q1 2021 and held it in 20 quarters. The position peaked at $1.65M in Q2 2022. 755 funds tracked by Wall St. Rank hold WST as of Q1 2026.

  • Kestra Advisory Services reported no remaining West Pharmaceutical position as of Q1 2026 after selling out during the quarter.
  • Kestra Advisory Services sold 2,228 West Pharmaceutical shares in Q1 2026, an estimated $613K.
  • Kestra Advisory Services first reported a position in West Pharmaceutical in Q1 2021 and held it in 20 quarters.
  • Kestra Advisory Services's West Pharmaceutical position peaked at $1.65M in Q2 2022.
  • 755 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on Kestra Advisory Services's 13F filing for Q1 2026, filed 30 Apr 2026.